Evidence map›Paper›PMID 38983057›Full record

ArticleFrontiers in ophthalmology2023

Role of

Warlen Miiller Rocha Araujo, Christiane Maria Ayo, Mariana Previato, Geraldo Magela de Faria, Fábio Batista Frederico, Rubens Camargo Siqueira, Gildásio Castello de Almeida, Vera Lúcia Pereira-Chioccola, Luiz Carlos de Mattos, Cinara Cássia Brandão

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Warlen Miiller Rocha AraujoFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Christiane Maria AyoFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Mariana PreviatoFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Geraldo Magela de FariaFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Fábio Batista FredericoFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Rubens Camargo SiqueiraFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Gildásio Castello de AlmeidaFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Vera Lúcia Pereira-ChioccolaDepartment of Parasitology, Instituto Adolfo Lutz-São Paulo, São Paulo, Brazil.
Luiz Carlos de MattosFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.
Cinara Cássia BrandãoFAMERP Toxoplasma Research Group, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ocular toxoplasmosis (OT) is an intraocular inflammation caused by Methods: Participants with a positive serology were classified into two distinct groups according to the presence (G1; Results: It was observed that the C/C genotype of the Conclusions: The -511C.T polymorphisms of the

Indexed as

cytokinesgenetic polymorphismsIL1β and IL10interleukinsocular toxoplasmosis

Identifiers

PMID38983057
PMCPMC11182258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.